We take a deep dive into the world of serious and unexpected adverse events, termed 'black swan' events, and their profound impact on drug safety, healthcare, and patient care.
Serious and unexpected adverse drug reactions – the ‘black swans’ of pharmacovigilance – can place enormous strain on safety monitoring systems. Drawing examples from the COVID-19 pandemic, François Montastruc from Toulouse University Hospital explains how we can get better at dealing with the unexpected.
Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:
Uppsala Reports editor
@UMCGlobalSafety
Prof. Singhal passed away on 19 April 2025. He is survived by his wife, children, and a large community of pharmacology researchers who had the privilege of training under him.
02 July 2025
How can we make healthcare safer for children? ISoP’s Angela Caro-Rojas shares insights ahead of World Patient Safety Day.
04 September 2025
Oman’s VigiMobile launch is more than a technical upgrade. It signals a strong commitment to patient safety and public participation in pharmacovigilance.
17 September 2025